[A Brief Discussion on the in Vitro Diagnostic Reagent Inspection Practice of

Area of Science:

• Regulatory Science
• Medical Device Compliance
• In Vitro Diagnostics

Context:

• The National Medical Products Administration released new Self-examination Management Regulations for Medical Device Registration on October 21, 2021.
• These regulations detail requirements for registration applicants regarding self-examination capabilities, reporting, and responsibilities.
• Ensuring the orderly development of medical device registration self-examination is a key objective.

Purpose:

• To interpret the key provisions of the new Self-examination Management Regulations for Medical Device Registration.
• To provide practical insights based on verification work with in vitro diagnostic reagents.
• To offer guidance for enterprises and regulatory bodies involved in medical device registration self-examination.

Summary:

• The study analyzes the 2021 Self-examination Management Regulations for Medical Device Registration, focusing on applicant requirements.
• It examines self-examination ability, report content, necessary declaration materials, and accountability.
• The analysis is grounded in practical experience with in vitro diagnostic reagent verification.

Impact:

• Aims to facilitate smoother implementation of the new regulations within the medical device industry.
• Provides a reference for companies seeking to comply with self-examination mandates.
• Supports regulatory bodies in overseeing the self-examination process for medical device registration.